Active Ingredient(s): Tenapanor Hydrochloride
FDA Approved: * September 12, 2019
Pharm Company: * ARDELYX INC
Category: Hyperphosphatemia

Tenapanor, used in form of tenapanor hydrochloride and sold under the brand name Ibsrela, is a treatment for adults with a disease of the gut called irritable bowel syndrome with constipation commonly referred to as IBS-C.[1] Tenapanor is a drug developed by Ardelyx, which acts as an inhibitor of the sodium-proton exchanger NHE3. This antiporter protein is found in the kidney and intestines, and normally acts to regulate the levels of sodium absorbed and secreted by the body. ... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Ibsrela 53.2 mg Oral Tablet
NDC: 73154-050
Ardelyx, Inc.